Serum procalcitonin a reliable biomarker - Video

Published On 2021-10-20T19:00:17+05:30 | Updated On 27 Oct 2021 5:29 PM IST

Overview

Ventilator-associated pneumonia (VAP) is a major hospital-acquired infection that accentuates morbidities in an already sick child and negatively impacts recovery and prognosis. Variuos morbidities associated with VAP included prolonged ventilation, long duration of higher antibiotics, increased ICU and hospital stay subsequently leading to increased health care costs.

Early identification of an evolving VAP helps in the early optimization of antibiotic therapy and correlates with early weaning from mechanical ventilation. For this purpose researchers from RML hospital New Delhi conducted a study to determine the role of serum procalcitonin as an early inflammatory marker for an early and provisional diagnosis of VAP among clinically suspected VAP patients in pediatric intensive care unit settings.

For more details, check out the full story on the link below:

Serum Procalcitonin- Reliable Biomarker To Diagnose Ventilator Associated Pneumonia In Kids: Study

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751